Drug Interactions with Grapefruit Juice

[1]  U. Fuhr,et al.  Grapefruit juice increases oral nimodipine bioavailability. , 1998, International journal of clinical pharmacology and therapeutics.

[2]  P. Watkins,et al.  Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[3]  Y. Oshima,et al.  Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. , 1997, Pharmacogenetics.

[4]  M. Larkin.  Out with the jab, in with painless pills , 1997, The Lancet.

[5]  K. Morris.  Grapefruit juice: the leveller of drug metabolism , 1997, The Lancet.

[6]  Morton B. Brown,et al.  Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. , 1997, The Journal of clinical investigation.

[7]  Y. Yamazoe,et al.  Grapefruit component interacting with rat and human P450 CYP3A: possible involvement of non-flavonoid components in drug interaction. , 1997, Biological and Pharmaceutical Bulletin.

[8]  S. E. Rau,et al.  Grapefruit juice—terfenadine single‐dose interaction: Magnitude, mechanism, and relevance , 1997, Clinical pharmacology and therapeutics.

[9]  J. Spence.  Drug interactions with grapefruit: Whose responsibility is it to warn the public? , 1997, Clinical pharmacology and therapeutics.

[10]  D. Back,et al.  Protease Inhibitors in Patients with HIV Disease , 1997, Clinical pharmacokinetics.

[11]  J. Oesterheld,et al.  Grapefruit juice and clomipramine: shifting metabolitic ratios. , 1997, Journal of clinical psychopharmacology.

[12]  M. E. Fitzsimmons,et al.  Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[13]  F. Guengerich,et al.  Cooperativity in oxidations catalyzed by cytochrome P450 3A4. , 1997, Biochemistry.

[14]  P. Woster,et al.  Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[15]  T. Whitsett,et al.  Influence of Grapefruit Juice on Caffeine Pharmacokinetics and Pharmacodynamics , 1996, Pharmacotherapy.

[16]  J. Potter,et al.  Vegetables, fruit, and cancer prevention: a review. , 1996, Journal of the American Dietetic Association.

[17]  M. Ishii,et al.  Treatment of psoriasis by cyclosporine and grapefruit juice. , 1996, Archives of dermatology.

[18]  P. Thomas,et al.  Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[19]  D. Edwards,et al.  Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice. , 1996, Life sciences.

[20]  D. Min,et al.  Effect of grapefruit juice on cyclosporine pharmacokinetics in renal transplant patients. , 1996, Transplantation.

[21]  R. Rouseff,et al.  Flavanone absorption after naringin, hesperidin, and citrus administration , 1996, Clinical pharmacology and therapeutics.

[22]  P. Pisarik.  Blood pressure-lowering effect of adding grapefruit juice to nifedipine and terazosin in a patient with severe renovascular hypertension. , 1996, Archives of family medicine.

[23]  D. Bailey,et al.  Erythromycin‐felodipine interaction: Magnitude, mechanism, and comparison with grapefruit juice , 1996, Clinical pharmacology and therapeutics.

[24]  W. Bennett.  What is the effect of grapefruit juice on cyclosporine pharmacokinetics? , 1996, Pediatric nephrology.

[25]  D. Min,et al.  Effect of Grapefruit Juice on the Pharmacokinetics and Pharmacodynamics of Quinidine in Healthy Volunteers , 1996, Journal of clinical pharmacology.

[26]  D. Shen,et al.  Oral first‐pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A‐mediated metabolism , 1996, Clinical pharmacology and therapeutics.

[27]  P. Agache,et al.  Inhibition of caffeine metabolism by 5-methoxypsoralen in patients with psoriasis. , 1996, British journal of clinical pharmacology.

[28]  R. Benton,et al.  Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram , 1996, Clinical pharmacology and therapeutics.

[29]  D. Wortham,et al.  Grapefruit Juice Alters the Systemic Bioavailability and Cardiac Repolarization of Terfenadine in Poor Metabolizers of Terfenadine , 1996, Journal of clinical pharmacology.

[30]  P. Neuvonen,et al.  Diltiazem enhances the effects of triazolam by inhibiting its metabolism , 1996, Clinical pharmacology and therapeutics.

[31]  M. A. Moseley,et al.  CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[32]  M. Reidenberg,et al.  Grapefruit juice and its flavonoids inhibit 11β‐hydroxysteroid dehydrogenase , 1996 .

[33]  U. Fuhr,et al.  The fate of naringin in humans: A key to grapefruit juice‐drug interactions? , 1995, Clinical pharmacology and therapeutics.

[34]  P. Neuvonen,et al.  Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice , 1995, Clinical pharmacology and therapeutics.

[35]  D. Bailey,et al.  Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulation. , 1995, British journal of clinical pharmacology.

[36]  D. Lowenthal,et al.  Effect of grapefruit juice on blood cyclosporin concentration , 1995, The Lancet.

[37]  S. Krähenbühl,et al.  Interaction between grapefruit juice and midazolam in humans , 1995, Clinical pharmacology and therapeutics.

[38]  A. Renwick,et al.  Factors affecting the absolute bioavailability of nifedipine. , 1995, British journal of clinical pharmacology.

[39]  U. Fuhr,et al.  Lacking effect of grapefruit juice on theophylline pharmacokinetics. , 1995, International journal of clinical pharmacology and therapeutics.

[40]  M. Ducharme,et al.  Disposition of intravenous and oral cyclosporine after administration with grapefruit juice , 1995, Clinical pharmacology and therapeutics.

[41]  C. I. Neutel,et al.  Risk of traffic accident injury after a prescription for a benzodiazepine. , 1995, Annals of epidemiology.

[42]  R. Platt,et al.  Terfenadine-associated ventricular arrhythmias and QTc interval prolongation. A retrospective cohort comparison with other antihistamines among members of a health maintenance organization. , 1995, Annals of epidemiology.

[43]  D. Lowenthal,et al.  Effect of grapefruit juice on blood cyclosporin concentration , 1995, The Lancet.

[44]  E. Lentjes,et al.  The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients , 1995, Clinical pharmacology and therapeutics.

[45]  A. Mclean,et al.  Influence of chronic ingestion of grapefruit juice on steady-state blood concentrations of cyclosporine A in renal transplant patients with stable graft function. , 1995, British journal of clinical pharmacology.

[46]  T. Hedner,et al.  Inhibition of 17 beta-estradiol metabolism by grapefruit juice in ovariectomized women. , 1994, Maturitas.

[47]  T. Cyr,et al.  Terfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[48]  J. Kolars,et al.  Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[49]  O Pelkonen,et al.  Metabolic interactions of methoxsalen and coumarin in humans and mice. , 1994, Biochemical pharmacology.

[50]  M. Green,et al.  Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[51]  H. Sigusch,et al.  Lack of effect of grapefruit juice on diltiazem bioavailability in normal subjects. , 1994, Die Pharmazie.

[52]  Y. Wong,et al.  Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[53]  H. Sigusch,et al.  Influence of grapefruit juice on the pharmacokinetics of a slow release nifedipine formulation. , 1994, Die Pharmazie.

[54]  M. Reidenberg,et al.  Inhibition of 11β-hydroxysteroid dehydrogenase obtained from guinea pig kidney by furoemide, naringenin and some other compounds , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[55]  W. Willett,et al.  Diet and health: what should we eat? , 1994, Science.

[56]  D. Bailey,et al.  Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics , 1993, Clinical pharmacology and therapeutics.

[57]  P. Botstein.  Is QT interval prolongation harmful? A regulatory perspective. , 1993, The American journal of cardiology.

[58]  D. Bailey,et al.  Grapefruit juice–felodipine interaction: Mechanism, predictability, and effect of naringin , 1993, Clinical pharmacology and therapeutics.

[59]  G. Pacouret,et al.  [A new cause of torsades de pointes: combination of terfenadine and troleandomycin]. , 1993, Annales de cardiologie et d'angeiologie.

[60]  U. Fuhr,et al.  Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. , 1993, British journal of clinical pharmacology.

[61]  J. Ménard,et al.  Unmasking of the hypotensive effect of nifedipine in normotensives by addition of the angiotensin converting enzyme inhibitor benazepril. , 1992, Journal of hypertension.

[62]  R. Woosley,et al.  Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin , 1992, Clinical pharmacology and therapeutics.

[63]  C. Regårdh,et al.  Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. , 1992, The Journal of pharmacology and experimental therapeutics.

[64]  U. Fuhr,et al.  Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. , 1992, Biochemical pharmacology.

[65]  J. Kolars,et al.  First-pass metabolism of cyclosporin by the gut , 1991, The Lancet.

[66]  B. Edgar,et al.  Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans , 1991, Clinical pharmacology and therapeutics.

[67]  D. Bailey,et al.  Interaction of citrus juices with felodipine and nifedipine , 1991, The Lancet.

[68]  F. Guengerich,et al.  In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. , 1990, Carcinogenesis.

[69]  M. A. Chambers,et al.  Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts. , 1990, The Journal of pharmacology and experimental therapeutics.

[70]  M. A. Chambers,et al.  Inhibition and induction of theophylline metabolism by 8-methoxypsoralen. In vivo study in rats and humans. , 1990, Drug metabolism and disposition: the biological fate of chemicals.

[71]  J. Spence,et al.  Ethanol enhances the hemodynamic effects of felodipine. , 1989, Clinical and investigative medicine. Medecine clinique et experimentale.

[72]  J. Brockmöller,et al.  Neurotoxicity caused by a high cyclosporine metabolite level. , 1989, Transplantation.

[73]  D. Mays,et al.  Activation of 8-methoxypsoralen by cytochrome P-450. Enzyme kinetics of covalent binding and influence of inhibitors and inducers of drug metabolism. , 1989, Biochemical pharmacology.

[74]  T. G. Baumgartner,et al.  The effects of grapefruit pectin on patients at risk for coronary heart disease without altering diet or lifestyle , 1988, Clinical cardiology.

[75]  P. Cheney,et al.  Methoxsalen is a potent inhibitor of the metabolism of caffeine in humans , 1987, Clinical pharmacology and therapeutics.

[76]  D. Mays,et al.  Inhibition and induction of drug biotransformation in vivo by 8-methoxypsoralen: studies of caffeine, phenytoin and hexobarbital metabolism in the rat. , 1987, The Journal of pharmacology and experimental therapeutics.

[77]  Guengerich Fp,et al.  Oxidation of 4-aryl- and 4-alkyl-substituted 2,6-dimethyl-3,5-bis(alkoxycarbonyl)-1,4-dihydropyridines by human liver microsomes and immunochemical evidence for the involvement of a form of cytochrome P-450. , 1986 .

[78]  C. T. Ueda,et al.  Absolute quinidine bioavailability , 1976, Clinical pharmacology and therapeutics.

[79]  J. Riov,et al.  Effect of gamma radiation on the synthesis of scopoletin and scopolin in grapefruit peel in relation to radiation damage. , 1971, Radiation research.

[80]  F. P. Griffiths,et al.  A chromatographic-fluorometric method for determination of naringin, naringenin rutinoside, and related flavanone blycosides in grapefruit juice and juice sacs. , 1965, Analytical biochemistry.

[81]  L. Goodman,et al.  THE PHARMACOLOGICAL BASIS OF THERAPEUTICS , 1966 .

[82]  P. Ryan,et al.  Dosing implications of a clinical interaction between grapefruit juice and cyclosporine and metabolite concentrations in patients with autoimmune diseases. , 1997, The Journal of rheumatology.

[83]  W. Baer-Dubowska,et al.  Inhibitory effects of naturally occurring coumarins on the metabolic activation of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in cultured mouse keratinocytes. , 1997, Carcinogenesis.

[84]  N Guthrie,et al.  Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. , 1996, Nutrition and cancer.

[85]  J. Ahlner,et al.  Effect of grapefruit juice on the pharmacokinetics of amlodipine in healthy volunteers , 1996, European Journal of Clinical Pharmacology.

[86]  Y. S. Lee,et al.  Grapefruit juice and its flavonoids inhibit 11 beta-hydroxysteroid dehydrogenase. , 1996, Clinical pharmacology and therapeutics.

[87]  Á. Balogh,et al.  Can grapefruit juice influence ethinylestradiol bioavailability? , 1996, Contraception.

[88]  W. Legrum,et al.  Metabolic and analytical interactions of grapefruit juice and 1,2-benzopyrone (coumarin) in man , 1996, European Journal of Clinical Pharmacology.

[89]  J. Vanakoski,et al.  PHARMACOKINETICS AND DISPOSITION , 2022 .

[90]  T. Hedner,et al.  Grapefruit juice: a possible source of variability in blood concentration of cyclosporin A. , 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[91]  D. Mays,et al.  Inhibition and induction of drug metabolism by psoralens: alterations in duration of sleep induced by hexobarbital and in clearance of caffeine and hexobarbital in mice. , 1991, Xenobiotica; the fate of foreign compounds in biological systems.

[92]  M. Leider.  Goodman & Gilman's The Pharmacological Basis of Therapeutics , 1985 .

[93]  S. Ranganna,et al.  Citrus fruits. Part II. Chemistry, technology, and quality evaluation. B. Technology. , 1983, Critical reviews in food science and nutrition.

[94]  S. Ranganna,et al.  Citrus fruits--varieties, chemistry, technology, and quality evaluation. Part II. Chemistry, technology, and quality evaluation. A. Chemistry. , 1983, Critical reviews in food science and nutrition.

[95]  R. Berry,et al.  Coumarins and psoralens in grapefruit peel oil , 1979 .

[96]  G. Jones,et al.  Identification of products produced by the anaerobic degradation of naringin by Butyrivibrio sp. C3. , 1971, Canadian journal of microbiology.

[97]  J. F. Fisher,et al.  A new coumarin from grapefruit peel oil. , 1967, Tetrahedron.